APA (7th ed.) Citation

Lu, X., Blättner, S., Dawood, M., Klauck, S., Fleischer, E., Kämmerer, P. W., & Efferth, T. (2022). Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling. European journal of pharmacology, 930, . https://doi.org/10.1016/j.ejphar.2022.175158

Chicago Style (17th ed.) Citation

Lu, Xiaohua, Sebastian Blättner, Mona Dawood, Sabine Klauck, Edmond Fleischer, Peer Wolfgang Kämmerer, and Thomas Efferth. "Novel Artemisinin Derivative FO8643 with Anti-angiogenic Activity Inhibits Growth and Migration of Cancer Cells via VEGFR2 Signaling." European Journal of Pharmacology 930 (2022). https://doi.org/10.1016/j.ejphar.2022.175158.

MLA (9th ed.) Citation

Lu, Xiaohua, et al. "Novel Artemisinin Derivative FO8643 with Anti-angiogenic Activity Inhibits Growth and Migration of Cancer Cells via VEGFR2 Signaling." European Journal of Pharmacology, vol. 930, 2022, https://doi.org/10.1016/j.ejphar.2022.175158.